Neuroimaging findings in patient series with mucopolysaccharidosis;Hallazgos neurorradiológicos en una serie de pacientes con mucopolisacaridosis

Neurologia

Volumn 27, Issue 7, 2012, Pages 407-413

  Calleja Gero, M L ^a   Gonzalez Gutierrez Solana L ^a   Lopez Marin L ^a   Lopez Pino M A ^a   Fournier Del Castillo, C ^a   Duat Rodriguez A ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Hunter syndrome; Hurler syndrome; Mucopolysaccharidoses; Neuroimaging findings; Neurological signs and symptoms; Virchow Robin perivascular spaces

Indexed keywords

ARTICLE; BRAIN VENTRICLE DILATATION; CISTERNA MAGNA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; MAROTEAUX LAMY SYNDROME; MUCOPOLYSACCHARIDOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SANFILIPPO SYNDROME; WHITE MATTER;

BRAIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTELLIGENCE TESTS; MAGNETIC RESONANCE IMAGING; MALE; MUCOPOLYSACCHARIDOSES; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84865406167     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2011.10.007     Document Type: Article

References (22)

1. Wraith J.E., Scarpa M., Beck M., Bodamer O.A., De Meirleir L., Guffon N., et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 2008, 167:267-277.
2. Martins A.M., Dualibi A.P., Norato D., Takata E.T., Santos E.S., Valadares E.R. Guidelines for the management of mucopolysaccharidosis type I. J Pediatr 2009, 155:S32-S46.
3. Vedolin L., Schwartz I.V.D., Komlos M., Schuch A., Azevedo A.C., Vieira T. Brain MRI in mucopolysaccaridosis. Effect of aging correlation with biochemical findings. Neurology 2007, 69:917-924.
4. Al Sawaf S., Mayatepek E., Hoffmann B. Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed. J Inherit Metab Dis 2008, 31:473-480.
5. Treatment and prevention of neurometabolic disorders. Neurology of hereditary metabolic diseases of children 2006, 501-517. McGraw Hill, New York. 3th ed. G. Lyon, G.M. Pastores, E.H. Kolodny (Eds.).
6. Gutiérrez-Solana L.G. Avances en el tratamiento de las enfermedades lisosomales en la infancia. Rev Neurol 2006, 43:S137-S144.
7. Gutiérrez-Solana L.G. Manifestaciones neurológicas del síndrome de Hunter. Rev Neurol 2008, 47:S9-S13.
8. Shinomiya N., Nagayama T., Fujioka Y., Aoki T. MRI in the mild type of mucopolysaccharidosis II (Hunterós syndrome). Neuroradiology 1996, 38:483-485.
9. Shapiro E.G., Klein K.A. Dementia in childhood: issues in neuropsychological assessment with application to the natural history ad treatment of degenerative storage diseases. Advances in child neuropsychology 1994, 2:119-171. Springer-Verlag, New York.
10. Wechsler D. Escala de Inteligencia de Wechsler para preescolar y primaria. WPPS-III (adaptación al castellano) 2009, TEA, Madrid.
11. Wechsler D. Escala de Inteligencia de Wechsler para niños-IV (adaptación al castellano) 2005, TEA, Madrid.
12. Newborg J., Stock J.R., Wnek L. Batelle. Inventario de desarrollo 1996, TEA, Madrid.
13. Seto T., Kono K., Morimoto K., Inoue Y., Shintaku H., Hattori H., et al. Brain Magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 2001, 50:79-92.
14. Tandon V., Williamson J.B., Cowie R.A., Wraith J.E. Spinal problems in mucopolysaccharidosis I (Hurler syndrome). J Bone Joint Surg Br 1996, 78:938-944.
15. Groeschel S., Brockmann K., Dechent P., Wilichowski E., Frahm J., Hanefeld F. Magnetic resonance imaging and proton magnetic resonance spectroscopy of megalencephaly and dilated Virchow-Robin spaces. Pediatr Neurol 2006, 34:35-40.
16. Bruna A-L., Martins I., Husson B., Landrieu P. Developmental dilatation of Virchow-Robin Spaces: A genetic disorder?. Pediatr Neurol 2009, 41:275-280.
17. Paciorkowski A.R., Greenstein R.M. When is enlargement of the subarachnoid spaces not benign? A genetic perspective. Pediatr Neurol 2007, 37:1-7.
18. Gabrielli O., Polorana G., Regnicolo L., Petroni V., Scarabino T., Coppa G.V., et al. Correlation between cerebral MRI abnormalities and mental Retardation in patients with mucopolysaccharidoses. Am J Med Genet 2004, 125A:224-231.
19. Vedolin L., Schwartz I.V., Komlos M., Schuch A., Puga A.C., Pinto L.L. Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR Am J Neuroradiol 2007, 28:1029-1033.
20. Valayannopoulos V., Boddaert N., Barbier V., Le Merrer M., Caillaud C., De Lonlay P. Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase. Mol Genet Metab 2010, 100:20-23.
21. Wang R.Y., Cambray-Forker E.J., Ohanian K., Karlin D.S., Covault K.K., Schwartz P.H., et al. Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II. Mol Genet Metab 2009, 98:406-411.
22. Kulkarni M.V., Williams J.C., Yeakley J.W., Andrews J.L., McArdle C.B., Narayana P.A., et al. Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses. Magn Reson Imaging 1987, 5:317-323.